1-7 of 7
Takemasa Tsuji
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs

Bowen Dong, Nataša Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy M. Bonura, Cindy Sander, Henry Withers, Mark D. Long, Colin Chavel, Scott H. Olejniczak, Hans Minderman, John M. Kirkwood, Robert P. Edwards, Walter J. Storkus, Pedro Romero, Pawel Kalinski
Journal: Cancer Immunology Research
Cancer Immunol Res (2024) 12 (10): 1421–1437.
https://doi.org/10.1158/2326-6066.CIR-24-0061
Published: 01 October 2024
View article titled, NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
Open the PDF for NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs in another window
Includes: Supplementary data
Journal Articles

Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy

Takemasa Tsuji, Akira Yoneda, Junko Matsuzaki, Anthony Miliotto, Courtney Ryan, Richard C. Koya, Kunle Odunsi
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (5): 594–604.
https://doi.org/10.1158/2326-6066.CIR-17-0434
Published: 30 April 2018
View article titled, Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy
Open the PDF for Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy in another window
Includes: Supplementary data
Journal Articles

Abstract B062: Differences of transcriptional profiles between long-term tolerized and memory CD4 T cells

Naoko Imai, Takemasa Tsuji, Nasser K. Altorki, Pei-Yu Kuo, Deepak Perumal, Samir Parekh, Sacha Gnjatic
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): B062.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-B062
Published: 03 January 2016
View article titled, Abstract B062: Differences of transcriptional profiles between long-term tolerized and memory CD4 T cells
Journal Articles

Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4+ T Cells

Junko Matsuzaki, Takemasa Tsuji, Immanuel Luescher, Lloyd J. Old, Protul Shrikant, Sacha Gnjatic, Kunle Odunsi
Journal: Cancer Immunology Research
Cancer Immunol Res (2014) 2 (4): 341–350.
https://doi.org/10.1158/2326-6066.CIR-13-0138
Published: 03 April 2014
View article titled, Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4<sup>+</sup> T Cells
Open the PDF for Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4<sup>+</sup> T Cells in another window
Includes: Supplementary data
Journal Articles

Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer

Kunle Odunsi, Junko Matsuzaki, Smitha R. James, Paulette Mhawech-Fauceglia, Takemasa Tsuji, Austin Miller, Wa Zhang, Stacey N. Akers, Elizabeth A. Griffiths, Anthony Miliotto, Amy Beck, Carl A. Batt, Gerd Ritter, Shashikant Lele, Sacha Gnjatic, Adam R. Karpf
Journal: Cancer Immunology Research
Cancer Immunol Res (2014) 2 (1): 37–49.
https://doi.org/10.1158/2326-6066.CIR-13-0126
Published: 02 January 2014
View article titled, Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer
Open the PDF for Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Effect of Montanide and Poly-ICLC Adjuvant on Human Self/Tumor Antigen-Specific CD4+ T Cells in Phase I Overlapping Long Peptide Vaccine Trial

Takemasa Tsuji, Paul Sabbatini, Achim A. Jungbluth, Erika Ritter, Linda Pan, Gerd Ritter, Luis Ferran, David Spriggs, Andres M. Salazar, Sacha Gnjatic
Journal: Cancer Immunology Research
Cancer Immunol Res (2013) 1 (5): 340–350.
https://doi.org/10.1158/2326-6066.CIR-13-0089
Published: 01 November 2013
View article titled, Effect of Montanide and Poly-ICLC Adjuvant on Human Self/Tumor Antigen-Specific CD4<sup>+</sup> T Cells in Phase I Overlapping Long Peptide Vaccine Trial
Open the PDF for Effect of Montanide and Poly-ICLC Adjuvant on Human Self/Tumor Antigen-Specific CD4<sup>+</sup> T Cells in Phase I Overlapping Long Peptide Vaccine Trial in another window
Includes: Supplementary data
Journal Articles

Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients

Shigehisa Kitano, Takemasa Tsuji, Caillian Liu, Daniel Hirschhorn-Cymerman, Chrisann Kyi, Zhenyu Mu, James P. Allison, Sacha Gnjatic, Jianda D. Yuan, Jedd D. Wolchok
Journal: Cancer Immunology Research
Cancer Immunol Res (2013) 1 (4): 235–244.
https://doi.org/10.1158/2326-6066.CIR-13-0068
Published: 06 October 2013
View article titled, Enhancement of Tumor-Reactive Cytotoxic CD4<sup>+</sup> T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients
Open the PDF for Enhancement of Tumor-Reactive Cytotoxic CD4<sup>+</sup> T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients in another window
Includes: Supplementary data